Biotech Industry Soars in 2012 as FDA Drug Approvals Reach a 15-Year High

RDInvesting Provides Stocks Research on Opko Health and Questcor Pharmaceuticals

Continue Reading

Solar Industry Impressing Investors With Gains in 2013 After a Dismal 2012

RDInvesting Provides Stock Research on Canadian Solar and JA Solar

Continue Reading

U.S. Food and Drug Administration Approved 30% More Drugs in 2012

RDInvesting Provides Stocks Research on Affymax and Incyte

Continue Reading

Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry-s Success

RDInvesting Provides Stocks Research on NPS Pharmaceuticals and Oncothyreon

Continue Reading

Resurgence in Japanese Demand Will Look to Boost Uranium Prices in 2013

RDInvesting Provides Stock Research on Cameco and Uranium Resources

Continue Reading

Uranium Industry Looks to Benefit as Japan Appears Ready to Embrace Nuclear Power Once Again

RDInvesting Provides Stock Research on Denison Mines and Uranium Energy

Continue Reading

U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous

Research Driven Investing Provides Stocks Research on Cytokinetics and Pluristem Therapeutics

Continue Reading

Biotech Industry Soars in 2012 as FDA Drug Approvals Reach a 15-Year High

RDInvesting Provides Stocks Research on United Therapeutics and Viropharma

Continue Reading

Solar Industry Impressing Investors With Gains in 2013 After a Dismal 2012

RDInvesting Provides Stock Research on LDK Solar and JinkoSolar

Continue Reading

FDA Approved a Total of 39 New Drugs in 2012 – Fifteen Year High

RDInvesting Provides Stocks Research on ACADIA Pharmaceuticals and Discovery Laboratories

Continue Reading